{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:13:39Z","timestamp":1791490419603,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ebiom.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T11:01:20Z","timestamp":1539082880000},"page":"461-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Re-thinking Alzheimer's disease therapeutic targets using gene-based tests"],"prefix":"10.1016","volume":"37","author":[{"given":"Man Ki","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-5887","authenticated-orcid":false,"given":"C. Mary","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","article-title":"The discovery of Alzheimer's disease","volume":"5","author":"Hippius","year":"2003","journal-title":"Dialogues Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.ebiom.2018.10.001_bb0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer's disease: an analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0015","author":"Kane"},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","article-title":"Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001841","article-title":"Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study","volume":"12","author":"Ostergaard","year":"2015","journal-title":"PLoS Med."},{"issue":"24","key":"10.1016\/j.ebiom.2018.10.001_bb0030","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1212\/WNL.0000000000003430","article-title":"Genetically decreased vitamin D and risk of Alzheimer disease","volume":"87","author":"Mokry","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2018.10.001_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer's disease: the path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1586\/14737175.2015.995638","article-title":"A pivotal moment in Alzheimer's disease and dementia: how global unity of purpose and action can beat the disease by 2025","volume":"15","author":"Vradenburg","year":"2015","journal-title":"Expert. Rev. Neurother."},{"issue":"4558","key":"10.1016\/j.ebiom.2018.10.001_bb0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"8000","key":"10.1016\/j.ebiom.2018.10.001_bb0050","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","article-title":"A hundred years of Alzheimer's disease research","volume":"52","author":"Hardy","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2018.10.001_bb0060","first-page":"6(4)","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","author":"Cummings","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"10043","key":"10.1016\/j.ebiom.2018.10.001_bb0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2018.10.001_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-2008-15213","article-title":"Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?","volume":"15","author":"Becker","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.ebiom.2018.10.001_bb0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcp.2012.11.014","article-title":"Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?","volume":"85","author":"Mullane","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.ebiom.2018.10.001_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2885","article-title":"Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'","volume":"224","author":"Castellani","year":"2011","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.ebiom.2018.10.001_bb0095","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1161\/ATVBAHA.115.305234","article-title":"Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart Disease","volume":"35","author":"Talmud","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.ebiom.2018.10.001_bb0100","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/2047487316682186","article-title":"Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles","volume":"24","author":"Gregson","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"Suppl. 4","key":"10.1016\/j.ebiom.2018.10.001_bb0105","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2164-15-S4-S5","article-title":"GWAS and drug targets","volume":"15","author":"Cao","year":"2014","journal-title":"BMC Genomics"},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094661","article-title":"Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease","volume":"9","author":"Escott-Price","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2018.10.001_bb0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jalz.2016.12.012","article-title":"Transethnic genome-wide scan identifies novel Alzheimer's disease loci","volume":"13","author":"Jun","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","article-title":"Use of genome-wide association studies for drug repositioning","volume":"30","author":"Sanseau","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.ebiom.2018.10.001_bb0125","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/nbt.2758","article-title":"Rational drug repositioning by medical genetics","volume":"31","author":"Wang","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.32499","article-title":"Alzheimer's Disease Genetics Consortium. Genomic variants, genes, and pathways of Alzheimer's disease: An overview","volume":"174","author":"Naj","year":"2017","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"12","key":"10.1016\/j.ebiom.2018.10.001_bb0135","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"D1","key":"10.1016\/j.ebiom.2018.10.001_bb0140","article-title":"Genenames.org: the HGNC and VGNC resources in","volume":"45","author":"Yates","year":"2017","journal-title":"Nucleic Acids Res 2017"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2018.10.001_bb0145","doi-asserted-by":"crossref","first-page":"D199","DOI":"10.1093\/nar\/gkt1076","article-title":"Data, information, knowledge and principle: back to metabolism in KEGG","volume":"42","author":"Kanehisa","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.ebiom.2018.10.001_bb0150","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trci.2016.07.001","article-title":"Alzheimer's drug-development pipeline: 2016","volume":"2","author":"Cummings","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"issue":"3","key":"10.1016\/j.ebiom.2018.10.001_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2011.01.019","article-title":"GATES: a rapid and powerful gene-based association test using extended Simes procedure","volume":"88","author":"Li","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.001_bb0170","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0175","first-page":"208","article-title":"Drugs for Alzheimer's disease: are they effective?","volume":"35","author":"Casey","year":"2010","journal-title":"PT"},{"issue":"3","key":"10.1016\/j.ebiom.2018.10.001_bb0180","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ebiom.2018.10.001_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaneurol.2014.2157","article-title":"Rarity of the Alzheimer disease-protective APP A673T variant in the United States","volume":"72","author":"Wang","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2018.10.001_bb0190","author":"Carroll"},{"issue":"9","key":"10.1016\/j.ebiom.2018.10.001_bb0195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd.2016.176","article-title":"Pharma pumps up anti-tau Alzheimer pipeline despite first Phase III failure","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","article-title":"Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects","volume":"130","author":"Vassar","year":"2014","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ebiom.2018.10.001_bb0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnagi.2015.00025","article-title":"Clearance of amyloid beta-protein and its role in the spreading of Alzheimer's disease pathology","volume":"7","author":"Thal","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0215","doi-asserted-by":"crossref","first-page":"b2680","DOI":"10.1136\/bmj.b2680","article-title":"How citation distortions create unfounded authority: analysis of a citation network","volume":"339","author":"Greenberg","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.001_bb0220","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.mayocp.2017.02.011","article-title":"Alzheimer disease: scientific breakthroughs and translational challenges","volume":"92","author":"Caselli","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0230","author":"ClinicalTrials.gov"},{"issue":"9","key":"10.1016\/j.ebiom.2018.10.001_bb0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-016-0361-4","article-title":"Apolipoprotein E as a therapeutic target in Alzheimer's disease: a review of basic research and clinical evidence","volume":"30","author":"Yamazaki","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ebiom.2018.10.001_bb0240","article-title":"Statins for the treatment of dementia","volume":"7","author":"McGuinness","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0245","doi-asserted-by":"crossref","first-page":"j1648","DOI":"10.1136\/bmj.j1648","article-title":"Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ebiom.2018.10.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001713","article-title":"Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis","volume":"11","author":"Proitsi","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0255","doi-asserted-by":"crossref","first-page":"501862","DOI":"10.4061\/2011\/501862","article-title":"Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and their relationships with Herpes Simplex, C. Pneumoniae, other suspect pathogens, and the immune system","volume":"2011","author":"Carter","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.ebiom.2018.10.001_bb0260","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s12035-014-8800-z","article-title":"MS4A Cluster in Alzheimer's Disease","volume":"51","author":"Ma","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.020","article-title":"Common variant in PTK2B is associated with late-onset Alzheimer's disease: A replication study and meta-analyses","volume":"621","author":"Li","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.ebiom.2018.10.001_bb0270","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1093\/hmg\/ddv092","article-title":"Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia","volume":"24","author":"Malik","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barabasi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0280","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"Guney","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ebiom.2018.10.001_bb0285","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.001_bb0290","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1039\/c3mb25382a","article-title":"Network-based drug repositioning","volume":"9","author":"Wu","year":"2013","journal-title":"Mol. BioSyst."},{"issue":"7","key":"10.1016\/j.ebiom.2018.10.001_bb0295","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/bioinformatics\/btx731","article-title":"DDR: efficient computational method to predict drug-target interactions using graph mining and machine learning approaches","volume":"34","author":"Olayan","year":"2018","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.ebiom.2018.10.001_bb0300","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/bfgp\/elr024","article-title":"Network-based methods for human disease gene prediction","volume":"10","author":"Wang","year":"2011","journal-title":"Brief Funct Genomics"},{"issue":"2","key":"10.1016\/j.ebiom.2018.10.001_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00439-013-1377-1","article-title":"Network-assisted analysis to prioritize GWAS results: principles, methods and perspectives","volume":"133","author":"Jia","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2164-15-199","article-title":"Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease","volume":"15","author":"Talwar","year":"2014","journal-title":"BMC Genomics"},{"issue":"Suppl. 9","key":"10.1016\/j.ebiom.2018.10.001_bb0315","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2164-16-S9-S2","article-title":"A computational framework for the prioritization of disease-gene candidates","volume":"16","author":"Browne","year":"2015","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13195-017-0252-z","article-title":"Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach","volume":"9","author":"Hu","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.001_bb0325","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","article-title":"A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease","volume":"21","author":"Mostafavi","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.ebiom.2018.10.001_bb0330","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/nn.4618","article-title":"Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry","volume":"20","author":"So","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ebiom.2018.10.001_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12819","article-title":"Gene expression-based drug repurposing to target aging","author":"Donertas","year":"2018","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0340","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12859-016-1065-y","article-title":"DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing","volume":"17","author":"Issa","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-018-0394-7","article-title":"Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates","volume":"10","author":"Vargas","year":"2018","journal-title":"Alzheimers Res. Ther."},{"issue":"8","key":"10.1016\/j.ebiom.2018.10.001_bb0350","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"issue":"10059","key":"10.1016\/j.ebiom.2018.10.001_bb0355","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2018.10.001_bb0360","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ebiom.2018.01.015","article-title":"Disconnect between genes associated with ischemic heart disease and targets of ischemic heart disease treatments","volume":"28","author":"Schooling","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2018.10.001_bb0365","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","article-title":"Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk","volume":"12","author":"Efthymiou","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.ebiom.2018.10.001_bb0370","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIRCGENETICS.110.957928","article-title":"The effect of survival bias on case-control genetic association studies of highly lethal diseases","volume":"4","author":"Anderson","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"4","key":"10.1016\/j.ebiom.2018.10.001_bb0375","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat. Genet."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418304122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418304122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:50:51Z","timestamp":1762455051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418304122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":75,"alternative-id":["S2352396418304122"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.001","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-thinking Alzheimer's disease therapeutic targets using gene-based tests","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}